GovChime
AWARDBPA CALLOther than small business

BPA call 75F40122F19004SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Overview

Award facts

Net obligations
$12.32M
$12,324,863of $12.82M potential value
Outlays (paid to date)
$10.50M
$10.50M paid of $12.32M obligated$10,500,718
Period of performance
Sep 29, 2022 to Sep 29, 2026
Ended
Modifications
8
Latest action Sep 29, 2025
Contract type
BPA call
PIID 75F40122F19004

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IT LIFECYCLE SUPPORT FOR THE HIVE SYSTEM

Dates and value

Award date
Signed on Sep 29, 2022
Current value
$12,324,863Base and exercised options
Potential value (if all options are exercised)
$12,820,031
Parent contract vehicle
75F40122A00016 (BPA, single award) — 36 orders recorded under it

Obligations by fiscal year of action

  • FY2025: $4,107,114
  • FY2024: $2,069,659
  • FY2023: $3,117,542
  • FY2022: $3,030,547

Total across 4 fiscal years: $12,324,863

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 29, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationRESTON, VA
UEIMMLKPW9JLX64
CAGE code6XWA8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugs; Biologics; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Reston, Fairfax County, Virginia 20190-3204
Congressional district (place of performance)
VA-11As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Labor hoursZ

Contract details

Service Contract Act labor standards
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 29, 2022Base obligation at award: $3,030,547
Latest action
Sep 29, 2025 — Other administrative actionModification P00008; obligation change +$2,274,959; administrative: no change in scope or value
Latest substantive action
Sep 22, 2025 — Option exercisedModification P00006; obligation change +$2,274,959
Actions by type
  • Base award1
  • Option exercised4
  • Other administrative action4
9 actions recorded, Sep 29, 2022 to Sep 29, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$2,274,959
Latest action: change in base and all options
$2,274,959

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
Yes

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
BPA callA
Parent vehicle type
BPAE
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
9

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2022/2022-0600-000
  • 075-2023/2023-0600-000
  • 075-2024/2024-0600-000
  • 075-2025/2025-0600-000
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.7: Operation and maintenance of equipment
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • U: Emergency P.L. 116-260
COVID-19 supplemental obligations
$512,432
COVID-19 supplemental outlays
$488,330